NASDAQ: CERC       Cerecor Inc
Last Price Today's Change   Day's Range   Trading Volume
4.27   -0.21 (4.69%)  4.205 - 4.446  8,070


Avg Volume (4 weeks):77,916
4 Weeks Range:4.205 - 5.41
4 Weeks Price Volatility (%):
52 Weeks Range:2.91 - 7.65
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Cerecor Inc is a clinical?stage biopharmaceutical company operating in the US. It is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The company holds a portfolio of novel clinical and preclinical compounds that we are developing for a variety of indications including CERC-301 which is an oral, adjunctive treatment of patients with major depressive disorder (MDD); CERC-501 which is for substance use disorders and adjunctive treatment of MDD and CERC-406 which is preclinical candidate of compounds that inhibit catechol?O?methyltransferase (COMT) within the brain. The company owns a right to COMTi platform is an enzyme that is critical for the inactivation and metabolism of dopamine.

  Be the first to like this.


1601  3659  597  3107 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACHN 6.760.00 
 GE 12.77+1.04 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 AMD 46.468-4.062 
 ECA 3.79-0.25 
 BBT 54.24+0.75 
 CHK 0.534+0.015 
Partners & Brokers